Skip to content

How to assess the individual sensitivity to intravenous anesthetic

How to assess the individual sensitivity to intravenous anesthetic - How to assess the individual sensitivity to intravenous anesthetic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004606
Enrollment
30
Registered
2010-11-23
Start date
2009-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Sponsors

Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients of ASA-PS I or II, who are scheduled mammectomy for their breast cancer

Exclusion criteria

Exclusion criteria: patients who has a disease in central nervous system. patients who are using the drugs that may influence the EEG, such as psychomimetic drugs

Design outcomes

Primary

MeasureTime frame
To obtain the relationship between the effect-site concentration and that required for maintenance of anesthesia.

Secondary

MeasureTime frame
To find a new method to evaluate the effect of anesthetic by investigating the concentration related changes of EEG.

Countries

Japan

Contacts

Public ContactSatoshi Hagihira

Osaka University Graduate School of Medicine Department of Anesthesiology and Intensive Care Medicine

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026